Category Archives: Technology

Unmet Need in the Migraine Space?

Allergan CEO David Pyott is bullish on Botox’s potential as a salve for chronic migraine. He’s also betting on a next-gen dihydroergotamine (DHE) – Levadex – from MAP Pharmaceuticals.
Also posted in FDA, Global, Marketing, Regulatory, Strategy | Tagged , , , , | 2 Comments

Close to Home: Is Good Health Communicable?

The 2011 Edelman Health Barometer suggests that—in the same way that we spread colds, diseases, and other illnesses from person to person—good health and healthy behaviors can also be spread. Can pharma play a pivotal role in the good-health epidemic? Energy. An active lifestyle. Mental and emotional stability. Absence of disease. Nutrition. These are some of [...]
Also posted in healthcare, social media | Tagged , , , | 1 Comment

The Rising Clout of the Patient

by Sarah Krüg In 2011, the patient’s clout as a stakeholder was firmly established, as reflected in several industry conferences. What’s next for the patient in 2012?
Also posted in Events, Meetings, Patient Communication, Strategy, leadership, patient education, social media | Tagged , , | 1 Comment

Off-Label Comments Online: Keep Doing What You're Doing, Says FDA

Those in favor of a less is more approach to FDA social media guidelines got what they wanted for the holidays: a trim, 15-page document on how to respond to unsolicited off-label comments
Also posted in Advertising, E-Media, FDA, Legal, Marketing, Regulatory, compliance, social media | Tagged | Leave a comment

A Simple Plan (to Save US Pharma Manufacturing)

Fernando Muzzio and Mauricio Futran propose a plan to turn around pharmaceutical manufacturing in the US. Pharmaceutical manufacturing in the US is in rapid decline. Higher regulatory standards for efficacy and safety, among other reasons, have led to a significant level of difficulty in replacing “blockbusters” developed in the 1980s and 1990s that are now coming [...]
Also posted in Guest Blog, Supply Chain | Tagged | 3 Comments